The H.O.P.E. Initiative
Helping Our Protectors Endure
With the onset of Covid-19, in-clinic treatment and programs have become extremely challenging or impossible, so the Nu-Life team immediately accelerated the Remote Treatment Program and began preparing for the changing requirements.
Nu-Life is moving quickly to complete the steps needed to begin treating patients. Initiatives were recently announced for healthcare workers, first responders and veterans.
We have also expanded H.O.P.E. to include those suffering from opioid addiction and the chronic symptoms and from the pain, anxiety, depression and sleeplessness caused directly or indirectly by the Covid-19 crisis. The H.O.P.E. Initiative allows us to mobilize very quickly to prepare to support those who need us, without delay.
Each Initiative will be one of our IRB approved clinical trials. In fact, H.O.P.E. will serve as our flagship Remote Treatment Program, beginning with the treatment of veterans, first responders and healthcare workers, with the intention to expand numbers of these patients rapidly. Patients treated in the H.O.P.E Initiative will not be charged for Nu-V3 or any part of the Nu-V3 treatment program.
We are pleased to announce the initial chapters of The H.O.P.E. Initiative, beginning with the midwest and northeastern United States, where members from our own Executive Medical Team will be in proximity to oversee the launching of these all important flagship initiatives.
View more on the specific H.O.P.E. Initiative chapters for 2021.